1
2
3
Weersma, R.L.S., Stokkers, P.C., van Bodegraven, A.A., Hogezand, R.J.P., Verspaget, H.W., Jong, D., van der Woude, C.J., Oldenburg, B., Linskens, R.K., Festen, E.A., van der Steege, G., Hommes, D.W., Crusius, J.B.A., Wijmenga, C., Nolte, I., Dijkstra, G.
Veröffentlicht in: Weersma , R L S , Stokkers , P C , van Bodegraven , A A , Hogezand , R J P , Verspaget , H W , Jong , D , van der Woude , C J , Oldenburg , B , Linskens , R K , Festen , E A , van der Steege , G , Hommes , D W , Crusius , J B A , Wijmenga , C , Nolte , I & Dijkstra , G 2009 , ' Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort ' , Gut , vol. 58 , no. 3 , pp. 388-395 . https://doi.org/10.1136/gut.2007.144865;
2009
Veröffentlicht in: Weersma , R L S , Stokkers , P C , van Bodegraven , A A , Hogezand , R J P , Verspaget , H W , Jong , D , van der Woude , C J , Oldenburg , B , Linskens , R K , Festen , E A , van der Steege , G , Hommes , D W , Crusius , J B A , Wijmenga , C , Nolte , I & Dijkstra , G 2009 , ' Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort ' , Gut , vol. 58 , no. 3 , pp. 388-395 . https://doi.org/10.1136/gut.2007.144865;
2009
4
Prevalence of-And risk factors for work disability in Dutch patients with inflammatory bowel disease
Spekhorst, L.M. (Lieke M.), Oldenburg, B. (Bas), Bodegraven, A.A. (Ad) van, De Jong, D.J. (Dirk J.), Imhann, F. (Floris), Van De Meulen-De Jong, A.E. (Andrea E.), Pierik, M. (Marieke), Van Der Woude, J.C. (Janneke C.), Dijkstra, G. (Gerard), D'Haens, G. (Geert), Löwenberg, M., Weersma, R.K. (Rinse), Festen, E.A.M. (Eleonora)
2017
2017
5
Gacesa, R, Kurilshikov, A, Vich Vila, A, Sinha, T, Klaassen, M A Y, Bolte, L A, Andreu-Sánchez, S, Chen, L, Collij, V, Hu, S, Dekens, J A M, Lenters, V C, Björk, J R, Swarte, J C, Swertz, M A, Jansen, B H, Gelderloos-Arends, J, Jankipersadsing, S, Hofker, M, Vermeulen, R C H, Sanna, S, Harmsen, H J M, Wijmenga, C, Fu, J, Zhernakova, A, Weersma, R K
Veröffentlicht in: Gacesa , R , Kurilshikov , A , Vich Vila , A , Sinha , T , Klaassen , M A Y , Bolte , L A , Andreu-Sánchez , S , Chen , L , Collij , V , Hu , S , Dekens , J A M , Lenters , V C , Björk , J R , Swarte , J C , Swertz , M A , Jansen , B H , Gelderloos-Arends , J , Jankipersadsing , S , Hofker , M , Vermeulen , R C H , Sanna , S , Harmsen , H J M , Wijmenga , C , Fu , J , Zhernakova , A & Weersma , R K 2022 , ' Environmental factors shaping the gut microbiome in a Dutch population ' , Nature , pp. 732–739 . https://doi.org/10.1038/s41586-022-04567-7;
2022
Veröffentlicht in: Gacesa , R , Kurilshikov , A , Vich Vila , A , Sinha , T , Klaassen , M A Y , Bolte , L A , Andreu-Sánchez , S , Chen , L , Collij , V , Hu , S , Dekens , J A M , Lenters , V C , Björk , J R , Swarte , J C , Swertz , M A , Jansen , B H , Gelderloos-Arends , J , Jankipersadsing , S , Hofker , M , Vermeulen , R C H , Sanna , S , Harmsen , H J M , Wijmenga , C , Fu , J , Zhernakova , A & Weersma , R K 2022 , ' Environmental factors shaping the gut microbiome in a Dutch population ' , Nature , pp. 732–739 . https://doi.org/10.1038/s41586-022-04567-7;
2022
6
Biemans, V.B.C., Sleutjes, J.A.M., de Vries, A.C., Bodelier, A.G.L., Dijkstra, G., Oldenburg, B., Lowenberg, M., van Bodegraven, A.A., van der Meulen-de Jong, A.E., de Boer, N.K.H., Srivastava, N., West, R.L., Romkens, T.E.H., Horje, C.H.T.S., Jansen, J.M., van der Woude, C.J., Hoekstra, J., Weersma, R.K., van Schaik, F.D.M., Hoentjen, F., Pierik, M.J.
Veröffentlicht in: Biemans , V B C , Sleutjes , J A M , de Vries , A C , Bodelier , A G L , Dijkstra , G , Oldenburg , B , Lowenberg , M , van Bodegraven , A A , van der Meulen-de Jong , A E , de Boer , N K H , Srivastava , N , West , R L , Romkens , T E H , Horje , C H T S , Jansen , J M , van der Woude , C J , Hoekstra , J , Weersma , R K , van Schaik , F D M , Hoentjen , F , Pierik , M J & Dutch Initiative Crohn and Colitis 2020 , ' Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry ' , Alimentary Pharmacology & Therapeutics , vol. 51 , no. 9 , pp. 880-888 . https://doi.org/10.1111/apt.15689;
2020
Veröffentlicht in: Biemans , V B C , Sleutjes , J A M , de Vries , A C , Bodelier , A G L , Dijkstra , G , Oldenburg , B , Lowenberg , M , van Bodegraven , A A , van der Meulen-de Jong , A E , de Boer , N K H , Srivastava , N , West , R L , Romkens , T E H , Horje , C H T S , Jansen , J M , van der Woude , C J , Hoekstra , J , Weersma , R K , van Schaik , F D M , Hoentjen , F , Pierik , M J & Dutch Initiative Crohn and Colitis 2020 , ' Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry ' , Alimentary Pharmacology & Therapeutics , vol. 51 , no. 9 , pp. 880-888 . https://doi.org/10.1111/apt.15689;
2020
7
Visschedijk, M. (Marijn), Alberts, R. (Rudi), Mucha, S. (Soren), Deelen, P. (Patrick), De Jong, D.J. (Dirk J.), Pierik, M. (Marieke), Spekhorst, L.M. (Lieke M.), Imhann, F. (Floris), Meulen-de Jong, A.E. (Andrea) van der, Van Janneke Der Woude, C., Bodegraven, A.A. (Ad) van, Oldenburg, B. (Bas), Löwenberg, M., Dijkstra, G. (Gerard), Ellinghaus, D. (David), Schreiber, S. (Stefan), Wijmenga, C. (Cisca), Rivas, M.A. (Manuel), Franke, A. (Andre), Diemen, C.C. (Cleo) van, Weersma, R.K. (Rinse K.)
2016
2016